This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
Agoraphobia Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment ( Medication, Therapy ); End User ( Hospitals, Specialty Clinics, Others ), and geography
Agoraphobia is a disease of anxiety. In circumstances where escape may be difficult or hard to reach, it can cause extreme fear. Situations that may trigger fear in people with agoraphobia include crowded or enclosed spaces, open and remote spaces, and being far from home. Panic attacks or panic disorders are also present in certain people with agoraphobia. They can prevent a person from leaving their home when the symptoms are severe. Agoraphobia can develop at any age, but the symptoms typically occur between the ages of 25-35 and affect women more frequently than men.
MARKET DYNAMIC
Factors driving the growth of the agoraphobia market are the growing prevalence of genetic predisposition, sedentary lifestyles, stress, deteriorating health standards in the contemporary lifestyles, coupled with lack of intimacy in relations. However, the social stigma regarding psychotherapy, low focus and penetration of mental health in society, tendency to hide mental disorders and reluctance to therapy and treatment is expected to hamper the growth of the market. Moreover, increasing substance abuse and rising awareness and screening is anticipated to boost the market growth.
MARKET SCOPE
The "Agoraphobia Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of agoraphobia market with detailed market segmentation by treatment and end user. The agoraphobia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in agoraphobia market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The agoraphobia market is segmented on the basis of treatment and end user. Based on treatment, the market is sub segmented as medication and therapy. The market by medication is segmented as antidepressants, anti-anxiety medications, and others. The market by therapy psychotherapy, cognitive behavioral therapy (CBT), and others. On the basis of end-user, the market is categorized as hospitals, specialty clinics, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the agoraphobia market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The agoraphobia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting agoraphobia market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the agoraphobia market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the agoraphobia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from agoraphobia market are anticipated to have lucrative growth opportunities in the future with the rising demand for agoraphobia in the global market. Below mentioned is the list of few companies engaged in the agoraphobia market.
The report also includes the profiles of key players in agoraphobia market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
AstraZeneca
Pfizer inc.
GlaxoSmithKline plc
Johnson & Johnson
Sandoz Inc.
Apotex Corp.
Mylan Pharmaceuticals Inc.
Eli Lilly & Co.
Bristol-Myers Squibb
Others
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Agoraphobia Market - By Treatment
1.3.2 Agoraphobia Market - By End User
1.3.3 Agoraphobia Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. AGORAPHOBIA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. AGORAPHOBIA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. AGORAPHOBIA MARKET - GLOBAL MARKET ANALYSIS
6.1. AGORAPHOBIA - GLOBAL MARKET OVERVIEW
6.2. AGORAPHOBIA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. AGORAPHOBIA MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT
7.1. OVERVIEW
7.2. TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. MEDICATION
7.3.1. Overview
7.3.2. Medication Market Forecast and Analysis
7.3.3. Antidepressants Market
7.3.3.1. Overview
7.3.3.2. Antidepressants Market Forecast and Analysis
7.3.4. Anti-anxiety Medications Market
7.3.4.1. Overview
7.3.4.2. Anti-anxiety Medications Market Forecast and Analysis
7.3.5. Others Market
7.3.5.1. Overview
7.3.5.2. Others Market Forecast and Analysis
7.4. THERAPY
7.4.1. Overview
7.4.2. Therapy Market Forecast and Analysis
7.4.3. Psychotherapy Market
7.4.3.1. Overview
7.4.3.2. Psychotherapy Market Forecast and Analysis
7.4.4. Cognitive Behavioral Therapy (CBT) Market
7.4.4.1. Overview
7.4.4.2. Cognitive Behavioral Therapy (CBT) Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
8. AGORAPHOBIA MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. SPECIALTY CLINICS
8.4.1. Overview
8.4.2. Specialty Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. AGORAPHOBIA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Agoraphobia Market Overview
9.1.2 North America Agoraphobia Market Forecasts and Analysis
9.1.3 North America Agoraphobia Market Forecasts and Analysis - By Treatment
9.1.4 North America Agoraphobia Market Forecasts and Analysis - By End User
9.1.5 North America Agoraphobia Market Forecasts and Analysis - By Countries
9.1.5.1 United States Agoraphobia Market
9.1.5.1.1 United States Agoraphobia Market by Treatment
9.1.5.1.2 United States Agoraphobia Market by End User
9.1.5.2 Canada Agoraphobia Market
9.1.5.2.1 Canada Agoraphobia Market by Treatment
9.1.5.2.2 Canada Agoraphobia Market by End User
9.1.5.3 Mexico Agoraphobia Market
9.1.5.3.1 Mexico Agoraphobia Market by Treatment
9.1.5.3.2 Mexico Agoraphobia Market by End User
9.2. EUROPE
9.2.1 Europe Agoraphobia Market Overview
9.2.2 Europe Agoraphobia Market Forecasts and Analysis
9.2.3 Europe Agoraphobia Market Forecasts and Analysis - By Treatment
9.2.4 Europe Agoraphobia Market Forecasts and Analysis - By End User
9.2.5 Europe Agoraphobia Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Agoraphobia Market
9.2.5.1.1 Germany Agoraphobia Market by Treatment
9.2.5.1.2 Germany Agoraphobia Market by End User
9.2.5.2 France Agoraphobia Market
9.2.5.2.1 France Agoraphobia Market by Treatment
9.2.5.2.2 France Agoraphobia Market by End User
9.2.5.3 Italy Agoraphobia Market
9.2.5.3.1 Italy Agoraphobia Market by Treatment
9.2.5.3.2 Italy Agoraphobia Market by End User
9.2.5.4 Spain Agoraphobia Market
9.2.5.4.1 Spain Agoraphobia Market by Treatment
9.2.5.4.2 Spain Agoraphobia Market by End User
9.2.5.5 United Kingdom Agoraphobia Market
9.2.5.5.1 United Kingdom Agoraphobia Market by Treatment
9.2.5.5.2 United Kingdom Agoraphobia Market by End User
9.2.5.6 Rest of Europe Agoraphobia Market
9.2.5.6.1 Rest of Europe Agoraphobia Market by Treatment
9.2.5.6.2 Rest of Europe Agoraphobia Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Agoraphobia Market Overview
9.3.2 Asia-Pacific Agoraphobia Market Forecasts and Analysis
9.3.3 Asia-Pacific Agoraphobia Market Forecasts and Analysis - By Treatment
9.3.4 Asia-Pacific Agoraphobia Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Agoraphobia Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Agoraphobia Market
9.3.5.1.1 Australia Agoraphobia Market by Treatment
9.3.5.1.2 Australia Agoraphobia Market by End User
9.3.5.2 China Agoraphobia Market
9.3.5.2.1 China Agoraphobia Market by Treatment
9.3.5.2.2 China Agoraphobia Market by End User
9.3.5.3 India Agoraphobia Market
9.3.5.3.1 India Agoraphobia Market by Treatment
9.3.5.3.2 India Agoraphobia Market by End User
9.3.5.4 Japan Agoraphobia Market
9.3.5.4.1 Japan Agoraphobia Market by Treatment
9.3.5.4.2 Japan Agoraphobia Market by End User
9.3.5.5 South Korea Agoraphobia Market
9.3.5.5.1 South Korea Agoraphobia Market by Treatment
9.3.5.5.2 South Korea Agoraphobia Market by End User
9.3.5.6 Rest of Asia-Pacific Agoraphobia Market
9.3.5.6.1 Rest of Asia-Pacific Agoraphobia Market by Treatment
9.3.5.6.2 Rest of Asia-Pacific Agoraphobia Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Agoraphobia Market Overview
9.4.2 Middle East and Africa Agoraphobia Market Forecasts and Analysis
9.4.3 Middle East and Africa Agoraphobia Market Forecasts and Analysis - By Treatment
9.4.4 Middle East and Africa Agoraphobia Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Agoraphobia Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Agoraphobia Market
9.4.5.1.1 South Africa Agoraphobia Market by Treatment
9.4.5.1.2 South Africa Agoraphobia Market by End User
9.4.5.2 Saudi Arabia Agoraphobia Market
9.4.5.2.1 Saudi Arabia Agoraphobia Market by Treatment
9.4.5.2.2 Saudi Arabia Agoraphobia Market by End User
9.4.5.3 U.A.E Agoraphobia Market
9.4.5.3.1 U.A.E Agoraphobia Market by Treatment
9.4.5.3.2 U.A.E Agoraphobia Market by End User
9.4.5.4 Rest of Middle East and Africa Agoraphobia Market
9.4.5.4.1 Rest of Middle East and Africa Agoraphobia Market by Treatment
9.4.5.4.2 Rest of Middle East and Africa Agoraphobia Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Agoraphobia Market Overview
9.5.2 South and Central America Agoraphobia Market Forecasts and Analysis
9.5.3 South and Central America Agoraphobia Market Forecasts and Analysis - By Treatment
9.5.4 South and Central America Agoraphobia Market Forecasts and Analysis - By End User
9.5.5 South and Central America Agoraphobia Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Agoraphobia Market
9.5.5.1.1 Brazil Agoraphobia Market by Treatment
9.5.5.1.2 Brazil Agoraphobia Market by End User
9.5.5.2 Argentina Agoraphobia Market
9.5.5.2.1 Argentina Agoraphobia Market by Treatment
9.5.5.2.2 Argentina Agoraphobia Market by End User
9.5.5.3 Rest of South and Central America Agoraphobia Market
9.5.5.3.1 Rest of South and Central America Agoraphobia Market by Treatment
9.5.5.3.2 Rest of South and Central America Agoraphobia Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL AGORAPHOBIA MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. AGORAPHOBIA MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANDOZ INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. APOTEX CORP.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MYLAN PHARMACEUTICALS INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ELI LILLY AND CO.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BRISTOL-MYERS SQUIBB
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. AstraZeneca
2. Pfizer inc.
3. GlaxoSmithKline plc
4. Johnson & Johnson
5. Sandoz Inc.
6. Apotex Corp.
7. Mylan Pharmaceuticals Inc.
8. Eli Lilly & Co.
9. Bristol-Myers Squibb
